INTERSTIM II
Report
- Report Number
- 3004209178-2014-12229
- Event Type
- Injury
- Date Received
- June 27, 2014
- Report Date
- June 6, 2014
- Manufacturer
- MEDTRONIC MED REL MEDTRONIC PUERTO RICO
- Product Code
- EZW
- PMA / PMN Number
- P970004
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- OTHER
Narratives
CONCOMITANT PRODUCTS: PRODUCT ID 3037, SERIAL # (B)(4); PRODUCT TYPE PROGRAMMER, PATIENT; PRODUCT ID 3889-28, LOT # V815657, IMPLANTED: (B)(6) 2011, EXPLANTED: (B)(6) 2014, PRODUCT TYPE LEAD; PRODUCT ID 37092, LOT # UNKNOWN, PRODUCT TYPE ACCESSORY. (B)(4). ANALYSIS OF THE PATIENT PROGRAMMER, SERIAL # (B)(4), FOUND NO ANOMALY. ANALYSIS OF THE LEAD, LOT #V815657, FOUND THE BODY CONDUCTORS CRUSHED. THERE WAS NO SIGNIFICANT ANOMALY. ANALYSIS OF THE NEUROSTIMULATOR, SERIAL # (B)(4), FOUND THE SETSCREW BACKED OUT TOO FAR. THERE WAS NO SIGNIFICANT ANOMALY. A KNOWN GOOD LEAD WAS ATTACHED TO THE RETURNED INS AND IMPEDANCES WERE ALL NORMAL. ANALYSIS OF THE UNKNOWN ANTENNA FOUND NO ANOMALY. THE INS, ANTENNA, AND PROGRAMMER WERE TESTED TOGETHER AS A SYSTEM WITH A KNOWN GOOD LEAD. THE PROGRAMMER WAS ABLE TO TURN THE INS ON/OFF AND ALSO INCREASE/DECREASE AMPLITUDE. THE SYSTEM FUNCTIONED CORRECTLY. (B)(4).
IT WAS REPORTED THAT THERE WERE HIGH IMPEDANCES AND THE LEAD AND IMPLANTABLE NEUROSTIMULATOR (INS) WERE REPLACED. THE PATIENT HAD LESS THAN 50% THERAPY RELIEF AT THE LEAD LOCATION. IT WAS NOTED THAT THE BATTERY DEPLETION WAS NORMAL. FOUR DAYS LATER, IT WAS REPORTED THAT THE IMPEDANCES WERE OVER 4,000 OHMS. THE CAUSE OF THE IMPEDANCE ISSUE WAS NOT KNOWN. SYSTEM REPLACEMENT RESOLVED THE ISSUE AND THAT PATIENT WAS FINE IN RECOVERY. THE PATIENT¿S THERAPY RESULTS WERE UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 377393 | INTERSTIM II | STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE | EZW | MEDTRONIC MED REL MEDTRONIC PUERTO RICO | 3058 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |